ホーム › 膀胱癌 › カンザス州 › Kansas City
Kansas City、KSにおける膀胱癌の臨床試験
Kansas Cityとその周辺地域（約30マイル以内）の拠点で、膀胱癌に関する12件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
被験者募集中第2相
- University of Kansas Cancer Center, Kansas City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21マイル先
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
被験者募集中第1相
- The University of Kansas Hospital Cambridge North Tower A, Kansas City
- The University of Kansas Hospital, Kansas City
- The University of Kansas Medical Center Medical Office Building, Kansas City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
被験者募集中第3相
- University of Kansas Cancer Center, Kansas City
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- The University of Kansas Cancer Center, Kansas City
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
被験者募集中第1/2相
- University of Kansas Medical Center, Kansas City
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
被験者募集中第1相
- The University of Kansas Hospital, Kansas City
- The University of Kansas Medical Center Medical Office Building, Kansas City
- University of Kansas Hospital Cambridge North Tower A, Kansas City
- 他1件
Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
被験者募集中観察研究
- University of Kansas Medical Center, Kansas City
- University of Kansas Medical Center, Kansas City
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
被験者募集中観察研究
- University of Kansas Medical Center, Kansas City
Blue Light Cystoscopy With Cysview® Registry
被験者募集中観察研究
- University of Kansas Medical Center, Kansas City
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
被験者募集中第2相
- The University of Kansas Cancer Center, Kansas City
LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
被験者募集中観察研究
- University of Kansas Medical Center, Kansas City
他の都市における膀胱癌の試験
- New York City, NY35件の研究
- Nashville, TN31件の研究
- Houston, TX31件の研究
- Dallas, TX27件の研究
- Washington, DC26件の研究
- Boston, MA26件の研究
- Baltimore, MD24件の研究
- Los Angeles, CA24件の研究
- St. Louis, MO22件の研究
- Seattle, WA21件の研究
- Philadelphia, PA21件の研究
- Edison, NJ21件の研究
Kansas Cityにおける他の研究
- 心血管疾患14件の研究
- 心不全13件の研究
- 肥満症13件の研究
- 間質性肺疾患13件の研究
- 嚢胞性線維症13件の研究
- 乳がん12件の研究
- 急性骨髄性白血病12件の研究
- 前立腺がん12件の研究
- 非小細胞肺癌11件の研究
- 肺がん11件の研究
- COPD9件の研究
- 喘息8件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。